RecruitingPHASE1, PHASE2NCT06120582

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

Studying Hemophilia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Biocad
Principal Investigator: Arina V Zinkina-Orikhan, MD
Director of Clinical Development Department, BIOCAD
Intervention: ANB-002, dose 1(genetic)
Enrollment: 28 enrolled
Eligibility: 18 years · MALE
Timeline: 2023 – 2029

Study locations (17)

Republican Scientific and Practical Center for Radiation Medicine and Human Ecology, Homyel, Belarus
Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus
State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital", Chelyabinsk, Russia
State budgetary healthcare institution Leningrad Regional Clinical Hospital, Gatchina, Russia
Kuzbass Clinical Hospital named after S.V. Belyaev, Kemerovo, Russia
Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency", Kirov, Russia
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders), Moscow, Russia
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia), Moscow, Russia
Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin", Moscow, Russia
LLC "Medis", Nizhny Novgorod, Russia
State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia
Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency, Saint Petersburg, Russia
City Polyclinic №37, Saint Petersburg, Russia
Almazov National Medical Research Centre, Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Healthcare of the Russian Federation, Samara, Russia
+2 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06120582 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials